EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from August 17, 2026 to August 21, 2026 (each inclusive), 705,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
17 August 2026	150,000	40.8773	6,131,595.00	XETR
18 August 2026	95,000	41.0382	3,898,629.00	XETR
19 August 2026	110,000	40.7755	4,485,305.00	XETR
20 August 2026	100,000	40.7786	4,077,860.00	XETR
21 August 2026	50,000	40.2673	2,013,365.00	CEUX
21 August 2026	200,000	40.3225	8,064,500.00	XETR

A total of 5,856,274 shares has been acquired within the framework of the first tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.